ATS 2020: Doxycycline Fails to Reduce Risk of COPD Exacerbation in Randomized Trial
Response to doxycycline differed depending on patients’ baseline eosinophil count
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.